Endocrinología

Diabetes Tipo 2

Insulin pump + CGM optimization, GLP-1 RA therapy (semaglutide), and metabolic surgery referral.

Opciones de Tratamiento

Centros Recomendados

$3,000

Desde

7-21 días

Espera Típica

Planes de Tratamiento para Diabetes Tipo 2

Compare opciones basadas en evidencia en los principales hospitales chinos — precios transparentes, tiempos de espera y recuperación.

Plan Principal

Insulin Pump + CGM Setup

Pump training + 14-day CGM placement + algorithm tuning.

Tiempo de Espera

5-7 days

Estancia Hospitalaria

3-5 days

Recuperación

Outpatient

Precio Estimado

Approx. $4,500

Ver Introducción Detallada — Procedimiento, Comparación de Precios y Más

Comparación de Precios: China vs EE.UU.

🇨🇳 China

$3,000

🇺🇸 EE.UU.

$17,500+

Ahorre hasta $14,500 por tratamiento

Pasos del Procedimiento

Pre-pump: diabetes education + carb counting mastery + glucose pattern analysis

Pump training: 2-day intensive education + insertion sites + bolus calculator

CGM setup: Dexcom G6/G7 or Libre 3 sensor placement + receiver/phone pairing

Hybrid closed-loop initiation: Tandem t:slim X2 with Control-IQ or Medtronic 780G

Initial settings: basal rates, carb ratios, ISF based on prior insulin needs

Weekly remote downloads + adjustments × 4 weeks initial

Quarterly pump downloads + HbA1c + comprehensive review

Annual: pump replacement, training updates

What is Insulin Pump + CGM Therapy?

A hybrid closed-loop system combines continuous glucose monitoring (CGM) with an insulin pump that automatically adjusts basal insulin delivery based on glucose trends. The latest "automated insulin delivery" (AID) systems achieve HbA1c targets with minimal hypoglycemia.

Why China?

Cost (pump + 1-year supplies): $5,500-$12,000 vs. $12,000-$25,000 in the US
Major brands available: Tandem, Medtronic 780G, Roche Accu-Chek
Domestic options: MicroTech Equil, Movecare patch pumps at lower cost
Comprehensive training: Endocrine team support included

Who is a candidate?

Type 1 diabetes
Type 2 diabetes on multiple daily injections with poor control
Hypoglycemia unawareness
Pregnancy with type 1 diabetes
Pediatric type 1 diabetes

Outcomes

HbA1c reduction: 0.5-1.5%. Time-in-range improvement: 70-80% (vs 50% MDI baseline). Severe hypoglycemia reduction: 70%+. Quality of life improvement: significant. Diabetic complications reduction: substantial long-term.

Reservar Consulta Gratuita WhatsApp

Los precios son rangos indicativos en USD basados en tarifas publicadas. La cotización final depende de sus registros médicos y hospital seleccionado — solicite una estimación personalizada gratuita.